BF Biosciences Limited (PSX:BFBIO)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
166.57
+1.48 (0.90%)
At close: Mar 27, 2025
Market Cap 14.71B
Revenue (ttm) 4.52B
Net Income (ttm) 428.05M
Shares Out 88.33M
EPS (ttm) 6.25
PE Ratio 26.65
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 325,453
Average Volume 1,195,880
Open 166.50
Previous Close 165.09
Day's Range 164.83 - 167.00
52-Week Range 76.06 - 253.97
Beta n/a
RSI 39.12
Earnings Date May 29, 2025

About BF Biosciences

BF Biosciences Limited, a diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products. It offers a range of products in the areas of nephrology, cardiology, gastroenterology, diabetes, oncology, anti-viral, and hepatology. The company was incorporated in 2006 and is headquartered in Raiwind, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited. [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Country Pakistan
Stock Exchange Pakistan Stock Exchange
Ticker Symbol BFBIO
Full Company Profile

Financial Performance

In 2024, BF Biosciences's revenue was 3.66 billion, an increase of 102.19% compared to the previous year's 1.81 billion. Earnings were 385.41 million, an increase of 158.57%.

Financial Statements

News

There is no news available yet.